Skip Navigation
Print Page

Staff Detail

Skip sharing on social media links
Share this:

Hazra, ROHAN

Formal Title:






6100 EXECUTIVE BLVD Room 4B11, MSC 7510
Bethesda Md 20892-7510
For FedEx use:
Rockville Md 20852

Topics in my portfolio:


Dr. Rohan Hazra is the chief of the Maternal and Pediatric Infectious Disease Branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). He joined the NICHD in 2007, and has overseen the Pediatric HIV AIDS Cohort Study (PHACS), a multicenter United States-based program that follows both perinatally HIV-infected youth and HIV-exposed/uninfected infants, children, and youth since 2008.  In addition, he is actively involved in pediatric HIV clinical trials and other observational studies in the United States and globally. 

He received his B.S. degree in biology from Yale University and his M.D. from the Johns Hopkins University School of Medicine. Following graduation from medical school, he completed a pediatric residency and pediatric infectious disease fellowship at Children's Hospital in Boston. Prior to joining NICHD he conducted clinical studies in pediatric HIV in the National Cancer Institute’s intramural program, where he continues to have an adjunct position. He is certified by the American Board of Pediatrics in both pediatrics and pediatric infectious diseases.


Publications (PubMed):

Title Authors Publication Date
Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.Kapetanovic S,Griner R,Zeldow B,Nichols S,Leister E,Gelbard HA,Miller TL,Hazra R,Mendez AJ,Malee K,Kammerer B,Williams PL,Pediatric HIV/AIDS Cohort Study TeamAIDS2014 Jan 28
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youth treated with tenofovir disoproxil fumarate.Havens PL,Hazra R,Stephensen CB,Kiser JJ,Flynn PM,Wilson CM,Rutledge B,Bethel J,Pan CG,Woodhouse LR,Van Loan MD,Liu N,Lujan-Zilbermann J,Baker A,Kapogiannis BG,Gordon CM,Mulligan K,the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 study teamAntivir Ther2014 Feb 17
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment.Williams PL,Abzug MJ,Jacobson DL,Wang J,Van Dyke RB,Hazra R,Patel K,Dimeglio LA,McFarland EJ,Silio M,Borkowsky W,Seage GR 3rd,Oleske JM,Geffner ME,International Maternal Pediatric and Adolescent AIDS Clinical Trials P219219C Study and the Pediatric HIVAIDS Cohort StudyAIDS2013 Jul 31
Association of higher plasma vitamin d binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Havens PL,Kiser JJ,Stephensen CB,Hazra R,Flynn PM,Wilson CM,Rutledge B,Bethel J,Pan CG,Woodhouse LR,Van Loan MD,Liu N,Lujan-Zilbermann J,Baker A,Kapogiannis BG,Gordon CM,Mulligan K,Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study TeamAntimicrob Agents Chemother2013 Nov
The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.Sohn AH,Hazra RJ Int AIDS Soc2013 Jun 18
Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children.Hazra R,Hance LF,Monteiro JP,Ruz NP,Machado DM,Saavedra M,Motta F,Harris DR,NISDI Pediatric Study Group 2012Pediatr Infect Dis J2013 Jul
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.Purswani M,Patel K,Kopp JB,Seage GR 3rd,Chernoff MC,Hazra R,Siberry GK,Mofenson LM,Scott GB,Van Dyke RB,Pediatric HIVAIDS Cohort StudyPediatr Infect Dis J2013 May
Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?Pace JE,Siberry GK,Hazra R,Kapogiannis BGClin Infect Dis2013 Apr
Combination antiretroviral use and preterm birth.Watts DH,Williams PL,Kacanek D,Griner R,Rich K,Hazra R,Mofenson LM,Mendez HA,Pediatric HIV/AIDS Cohort StudyJ Infect Dis2013 Feb 15
Bone mineral density in children and adolescents with perinatal HIV infection.DiMeglio LA,Wang J,Siberry GK,Miller TL,Geffner ME,Hazra R,Borkowsky W,Chen JS,Dooley L,Patel K,van Dyke RB,Fielding RA,Gurmu Y,Jacobson DL,Pediatric HIVAIDS Cohort Study (PHACS)AIDS2013 Jan 14
Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus-Exposed Uninfected Infants.Williams PL,Crain MJ,Yildirim C,Hazra R,Van Dyke RB,Rich K,Read JS,Stuard E,Rathore M,Mendez HA,Watts DH,for the Pediatric HIV/AIDS Cohort StudyJAMA Pediatr2014 Nov 10
Safety of In Utero and Neonatal Antiretroviral Exposure: Cognitive and Academic Outcomes in HIV-exposed, Uninfected Children 5-13 Years of Age.Nozyce ML,Huo Y,Williams PL,Kapetanovic S,Hazra R,Nichols S,Hunter S,Smith R,Seage GR 3rd,Sirois PA,Pediatric HIVAIDS Cohort StudyPediatr Infect Dis J2014 Nov
Increased Coronary Vessel Wall Thickness in HIV-Infected Young Adults.Abd-Elmoniem KZ,Unsal AB,Eshera S,Matta JR,Muldoon N,McAreavey D,Purdy JB,Hazra R,Hadigan C,Gharib AMClin Infect Dis2014 Dec 15
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology